“As API suppliers, we have been a bit in the middle,” Gomes claims. “We see what is happening with our clients that are generic or branded drug manufacturers, but we also see what is going on at the earliest stage of the supply chain.The forward-on the lookout statements contained With this information release are created as in the date hereo